{
    "code": "56031801",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56031801",
    "time": "2023-10-27 12:03:24",
    "許可證字號": "衛部醫器輸字第031801號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD11109",
    "有效日期": "117\/11\/20",
    "發證\/登錄日期": "107\/11\/20",
    "許可證\/登錄種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05603180100",
    "中文品名": "靈芝鴉片酵素免疫試劑",
    "英文品名": "LZI Opiates EIA Kit",
    "效能": "本產品用於定性或半定量測定人類尿液中的鴉片，需搭配自動生化分析儀使用，其閾值為300ng\/mL(以morphine校正)。",
    "醫器規格": "0001、0020b、0021b、0022、0023、0024、0025、0027、0028，以下空白。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A3650鴉片試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣尖端先進生技醫藥股份有限公司",
    "申請商地址": "臺北市大安區復興南路二段363號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "LIN-ZHI INTERNATIONAL, INC",
            "製造廠廠址": "2945 Oakmead Village Court Santa Clara, California 95051 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560318010001-108-01-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56031801&Seq=001&Type=9"
        },
        {
            "title": "560318010002-108-01-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56031801&Seq=001&Type=8"
        }
    ]
}